desipramine has been researched along with Brain Damage, Chronic in 2 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BARRINGER, TJ | 1 |
Edwards, WR | 1 |
2 other studies available for desipramine and Brain Damage, Chronic
Article | Year |
---|---|
CLINICAL TRIAL OF DESIPRAMINE IN THE TREATMENT OF DEPRESSION.
Topics: Brain; Brain Damage, Chronic; Brain Injuries; Depression; Depressive Disorder; Desipramine; Drug The | 1965 |
Treatment of poisoning by anti-depressant drugs.
Topics: Brain Damage, Chronic; Desipramine; Humans; Hydrocortisone; Infant; Procaine; Thiopental; Urea | 1967 |